[{"AccountsPayableCurrent_0_Q2_USD":2467000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":54000.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q2_shares":5982476.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":574000.0,"IncreaseDecreaseInOtherOperatingLiabilities_2_Q2_USD":19000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":226000.0,"ShareBasedCompensation_2_Q2_USD":1734000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":6629000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":1788000.0,"PreferredStockValue_0_Q2_USD":null,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"OperatingIncomeLoss_2_Q2_USD":-13032000.0,"OperatingIncomeLoss_1_Q2_USD":-5652000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":403000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":2000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":-4386000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":358000.0,"RestructuringAndRelatedCostNumberOfPositionsEliminated_2_Q2_Employee":0.0,"RestrictedCashNoncurrent_0_Q2_USD":245000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":2000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":37115000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":759000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":-150000.0,"MarketableSecuritiesCurrent_0_Q2_USD":0.0,"OperatingExpenses_2_Q2_USD":13032000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":34000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_2_Q2_USD":57500000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":71134000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":-49000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":-32000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-12686000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-5631000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":237509000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":509000.0,"OperatingExpenses_1_Q2_USD":5652000.0,"DepreciationAndAmortization_2_Q2_USD":68000.0,"DepreciationAndAmortization_1_Q2_USD":34000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-4251000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":8000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":1000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-12629000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-5598000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":6403000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":3864000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":1080000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-0.35,"CommonStockValue_0_Q2_USD":4000.0,"CommonStockSharesOutstanding_0_Q2_shares":36444732.0,"CommonStockSharesIssued_0_Q2_shares":36446853.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":70889000.0,"AssetsCurrent_0_Q2_USD":73749000.0,"Assets_0_Q2_USD":74342000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":2801790.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.15,"RestructuringCharges_1_Q2_USD":0.0,"Liabilities_0_Q2_USD":3598000.0,"LiabilitiesCurrent_0_Q2_USD":3564000.0,"CommonStockSharesAuthorized_0_Q2_shares":150000000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"CommitmentsAndContingencies_0_Q2_USD":null,"AccruedLiabilitiesCurrent_0_Q2_USD":1097000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":36445460.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":36446235.0,"StockholdersEquity_0_Q2_USD":70744000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":74342000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-166769000.0,"ProfitLoss_2_Q2_USD":-12637000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":2860000.0,"NetIncomeLoss_1_Q2_USD":-5599000.0,"NetIncomeLoss_2_Q2_USD":-12637000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-20383000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":57500000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":-2000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":348000.0,"RestructuringCharges_2_Q2_USD":100000.0,"Ticker":"ACET","CIK":"1720580","name":"RESTORBIO, INC.","OfficialName":"Adicet Bio Inc. Common Stock ","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"311478265.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200731"}]